National Stroke Association presents
a webcast for Stroke Professionals
Treatment of Symptomatic Intracranial Atherosclerotic Disease
Event Date: September 20, 2009
Marc I. Chimowitz, MBChB
Medical University of South Carolina, Charleston, SC*
David Fiorella, MD, PhD
Stony Brook University Hospital, Stony Brook, NY*
National Stroke Association intends to narrow the gap between knowledge and practice with respect to intracranial stenosis and stroke risk. This program explores intracranial stenosis and stroke risk, reviews the latest medical and endovascular literature and discusses the NIH-funded randomized trial (Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis) SAMMPRIS comparing stenting to medical therapy.
At the conclusion of the program, participants should be able to:
- Identify recurrent stroke risk associated with symptomatic patients with high levels of stenosis in the intracranial arteries.
- Summarize the rationale for aggressive risk factor management.
- Discuss current evidence-based treatment options, including medical management and interventional procedures.
- Describe goals of the SAMMPRIS trial
This program is designed for neurologists, interventionalists, emergency medicine physicians, primary care physicians and internal medicine physicians.
Continuing medical education credits (CME and CE) are not available for this program.
Please check our Medical Education area for additional CME opportunities.
The content and views presented in this educational program are those of the authors and faculty and do not necessarily reflect those of National Stroke Association.
All faculty members participating in medical education programs are expected to disclose any real or perceived conflict of interest related to the content of their presentations. Before the program, all faculty will disclose the existence of any relationship(s) they might have with the manufacturer(s) of any commercial products or services to be discussed during their presentation(s).